Cellular and Molecular Insights into Gynecologic Tumors
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 30 September 2026 | Viewed by 1192
Special Issue Editors
2. Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
Interests: infertility; reproductive endocrinology; IVF; myoma; gynecology; perinatology; pharmacogenetic; personalized medicine; PCOS; endometriosis
Interests: cancer biology; cancer genetics; endometriosis; pathology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gynecologic cancers, including ovarian, endometrial, and cervical tumors, remain major challenges in women’s health. Understanding the cellular and molecular mechanisms driving these cancers is essential for improving diagnosis, prognosis, and treatment strategies. This Special Issue aims to explore recent advances in the biology of gynecologic tumors, with a focus on cancer stem cells, genetic mutations, and the tumor microenvironment. We welcome contributions that highlight molecular pathways involved in tumorigenesis, metastasis, and resistance to therapy, as well as emerging biomarkers for early detection. Studies that offer novel therapeutic approaches, including targeted treatments and immunotherapies, are also encouraged.
We look forward to advancing our understanding of gynecologic tumors through this collection of cutting-edge research.
Dr. Mladen Anđić
Prof. Dr. Jianjun Wei
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic cancers
- cervical cancer
- endometrial cancer
- ovarian tumors
- tumor microenvironment
- molecular biomarkers
- genetic mutations
- targeted therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
